MX9301014A - Composiciones citoprotectora y metodos para preparar y usar las mismas. - Google Patents

Composiciones citoprotectora y metodos para preparar y usar las mismas.

Info

Publication number
MX9301014A
MX9301014A MX9301014A MX9301014A MX9301014A MX 9301014 A MX9301014 A MX 9301014A MX 9301014 A MX9301014 A MX 9301014A MX 9301014 A MX9301014 A MX 9301014A MX 9301014 A MX9301014 A MX 9301014A
Authority
MX
Mexico
Prior art keywords
compositions
cytoprotector
preparing
methods
drug
Prior art date
Application number
MX9301014A
Other languages
English (en)
Inventor
Alain Martin
Original Assignee
Warner Lambert Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner Lambert Co filed Critical Warner Lambert Co
Publication of MX9301014A publication Critical patent/MX9301014A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A61K31/355—Tocopherols, e.g. vitamin E
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A61K31/375—Ascorbic acid, i.e. vitamin C; Salts thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36—Carboxylic acids; Salts or anhydrides thereof
    • A61K8/361—Carboxylic acids having more than seven carbon atoms in an unbroken chain; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36—Carboxylic acids; Salts or anhydrides thereof
    • A61K8/365—Hydroxycarboxylic acids; Ketocarboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/52—Stabilizers
    • A61K2800/522—Antioxidants; Radical scavengers

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Emergency Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Birds (AREA)
  • Dermatology (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Chemical And Physical Treatments For Wood And The Like (AREA)
  • Fats And Perfumes (AREA)
  • Anti-Oxidant Or Stabilizer Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

La presente invención se relaciona con composiciones citoprotectoras para impedir y reducir el daño a las células de mamífero a partir de un medicamento que tiene propiedades citotóxicas.
MX9301014A 1992-02-25 1993-02-24 Composiciones citoprotectora y metodos para preparar y usar las mismas. MX9301014A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US84134292A 1992-02-25 1992-02-25

Publications (1)

Publication Number Publication Date
MX9301014A true MX9301014A (es) 1993-09-01

Family

ID=25284623

Family Applications (1)

Application Number Title Priority Date Filing Date
MX9301014A MX9301014A (es) 1992-02-25 1993-02-24 Composiciones citoprotectora y metodos para preparar y usar las mismas.

Country Status (7)

Country Link
EP (1) EP0627917A1 (es)
JP (1) JPH07505145A (es)
AU (2) AU4275793A (es)
CA (1) CA2129732A1 (es)
MX (1) MX9301014A (es)
WO (1) WO1993016690A1 (es)
ZA (1) ZA931297B (es)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5658956A (en) * 1991-03-01 1997-08-19 Warner-Lambert Company Bioadhesive-wound healing compositions and methods for preparing and using same
US5662934A (en) * 1993-01-05 1997-09-02 Najarian; Thomas Compositions and methods for lowering cholesterol while maintaining antioxidant levels
EP0804181A4 (en) * 1995-09-19 2005-02-02 Cellular Sciences Inc METHOD AND COMPOSITION FOR TREATING MAMMALIAN DISEASES CAUSED BY INFLAMMATORY REACTION
WO1997041848A1 (en) * 1996-05-08 1997-11-13 The Government Of The United States, Represented By The Secretary Of The Army Pharmaceutical compositions containing alpha-keto carboxylates
BR9808157A (pt) * 1997-03-04 2000-03-28 Wisconsin Alumni Res Found Processo de inibição do desenvolvimento de células tumorais e de tumor e composição farmacêutica
EP1001738B1 (en) 1997-06-20 2003-07-23 Prometics Bodycare Limited A skin-protective composition
EP1037623A1 (en) * 1997-12-12 2000-09-27 Warner-Lambert Company Antihyperlipidemic statin-lp(a) inhibitor combinations
US6218383B1 (en) 1998-08-07 2001-04-17 Targacept, Inc. Pharmaceutical compositions for the prevention and treatment of central nervous system disorders
CA2270853A1 (en) 1999-05-05 2000-11-05 Unknown Ceruloplasmin and antioxidant compositions comprising the same and their uses as neuroprotective agent
US6183796B1 (en) * 1999-09-20 2001-02-06 Lipotech Partners Limited Partnership Monounsaturated fatty acid compositions and method of making
WO2003032941A2 (de) * 2001-10-13 2003-04-24 Beiersdorf Ag Kosmetische und/oder dermatologische wirkstoffkombination
WO2006073461A2 (en) * 2004-05-05 2006-07-13 Clearant Inc. Methods of sterilizing biological mixtures using alpha-keto acids
GB0603975D0 (en) * 2006-03-01 2006-04-05 Etren Methods and agents for reducing oxidative stress
CN109662964A (zh) 2010-02-09 2019-04-23 约翰斯.霍普金斯大学 用于改善认知功能的方法和组合物
WO2013188509A1 (en) * 2012-06-15 2013-12-19 Creighton University Seizure therapy
CA2891122C (en) 2012-11-14 2021-07-20 The Johns Hopkins University Methods and compositions for treating schizophrenia
WO2014144663A1 (en) 2013-03-15 2014-09-18 The Johns Hopkins University Methods and compositions for improving cognitive function
AU2014228512A1 (en) 2013-03-15 2015-10-01 Agenebio, Inc. Methods and compositions for improving cognitive function
CN112843005B (zh) 2015-05-22 2023-02-21 艾吉因生物股份有限公司 左乙拉西坦的延时释放药物组合物

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4696917A (en) * 1985-08-01 1987-09-29 Lindstrom Richard L Irrigation solution
KR910000101A (ko) * 1988-06-02 1991-01-29 유다까 미시마 효소형성 억제제
PH31403A (en) * 1991-03-01 1998-10-29 Warner Lambert Co Therapeutic compositions to protect and recuscitate mammalian cells and methods for preparing same.
WO1993010776A1 (en) * 1991-11-26 1993-06-10 Warner-Lambert Company Wound healing compositions containing a pyruvate, an antioxidant and a mixture of fatty acids

Also Published As

Publication number Publication date
EP0627917A1 (en) 1994-12-14
ZA931297B (en) 1994-06-27
CA2129732A1 (en) 1993-09-02
JPH07505145A (ja) 1995-06-08
AU4275793A (en) 1993-09-13
AU3315397A (en) 1997-10-30
WO1993016690A1 (en) 1993-09-02

Similar Documents

Publication Publication Date Title
MX9301014A (es) Composiciones citoprotectora y metodos para preparar y usar las mismas.
ATE193550T1 (de) Rekonstruiertes knorpelgewebe
MX9201139A (es) Nuevos esteres de amino alcoholes bi- y triciclicos, procedimiento para su reparacion y composiciones farmaceuticas que los c0ntienen.
GT199600026A (es) Isotiazolonas
GT199900102A (es) Fenoxipropanolaminas, procedimiento para su preparacìon y composiciones farmacèuticasque las contienen.
ES2195970T3 (es) L-ribavirina y usos de la misma.
NO962073L (no) Amfifiliske imidazoliniumderivater
DK0868505T3 (da) Chondrogen in vitro induktion af humane mesenchymstamceller
ES2175443T3 (es) Compuestos de naptopirano y articulos que los contienen.
AR031975A1 (es) Compuestos analogos de (1r,cis)-4-(6-amino-9h-purin-9-il) -2-ciclopenteno-1-metanol, proceso para su preparacion, su uso en el tratamiento de infecciones virales, y envase que los contiene
MX9203647A (es) Materiales absorbentes y metodos para su produccion.
DE3379792D1 (en) Acrylic fibers for producing carbon fibers
ES2260933T3 (es) Derivados del acido de tiazolina.
ES2067854T3 (es) Polisulfato de derivado de ciclodextrina y procedimiento para preparar el mismo.
MX9400341A (es) Derivados de los acidos quinolon- y naftiridon-carboxilicos, procedimiento para su obtencion y agentes antibacterianos y aditivos para piensos que los contienen.
DK0700380T3 (da) N-Alkylthiopolyaminderivater som radioprotektive midler
AR036926A1 (es) Las gonadotrofinas para foliculo-genesis
ES2145452T3 (es) Metodo para preparar ureas ciclicas n,n'-disustituidas.
ES2003856T3 (es) Derivado del acido tiazolidin-4-carboxilico, su preparacion y composiciones farmaceuticas que lo contienen.
CO5070654A1 (es) Derivados de acidos fenilaminoalquilcarboxilicos y composiciones farmaceuticas que los comprenden
ES2062202T3 (es) Derivado del indol.
ES2179529T3 (es) Compuestos biaromaticos unidos por un radical heteroetinileno, y composiciones farmaceuticas y cosmeticas que los contienen.
ES2179070T3 (es) Derivados del taxano c9 y composiciones farmaceuticas que las contienen.
BR9808642A (pt) Processo para preparar eprosartan
ES2093752T3 (es) Complejos de hierro que contienen conalbumina y sus derivados.